These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 25338765)
1. Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency. Janjgava S; Zerekidze T; Uchava L; Giorgadze E; Asatiani K Eur J Med Res; 2014 Oct; 19(1):56. PubMed ID: 25338765 [TBL] [Abstract][Full Text] [Related]
2. Prevalence, Pathophysiology, and Management of Androgen Deficiency in Men with Metabolic Syndrome, Type 2 Diabetes Mellitus, or Both. Taylor SR; Meadowcraft LM; Williamson B Pharmacotherapy; 2015 Aug; 35(8):780-92. PubMed ID: 26289308 [TBL] [Abstract][Full Text] [Related]
3. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Boyanov MA; Boneva Z; Christov VG Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074 [TBL] [Abstract][Full Text] [Related]
4. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study). Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A; Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040 [TBL] [Abstract][Full Text] [Related]
5. The effects of metformin and diet on plasma testosterone and leptin levels in obese men. Ozata M; Oktenli C; Bingol N; Ozdemir IC Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532 [TBL] [Abstract][Full Text] [Related]
7. Patients with testosterone deficiency syndrome and type 2 diabetes. Corona G; Maggi M Arch Esp Urol; 2013 Sep; 66(7):711-22. PubMed ID: 24047631 [TBL] [Abstract][Full Text] [Related]
8. [Fibroblast growth factor-21 as a marker of premature aging in young and middled-aged men with type 2 diabetes]. Zagarskikh EY; Proshchai GA; Vorokhobina NV Urologiia; 2018 Mar; (1):92-95. PubMed ID: 29634140 [TBL] [Abstract][Full Text] [Related]
9. [Relevant clinical and biological criteria for the diagnosis of androgen deficiency in the aging male (ADAM)]. Seisen T; Rouprêt M; Gallais JL; Costa P Prog Urol; 2012 Jun; 22 Suppl 1():S21-6. PubMed ID: 22770497 [TBL] [Abstract][Full Text] [Related]
10. Are the adverse effects of glitazones linked to induced testosterone deficiency? Carruthers M; Trinick TR; Jankowska E; Traish AM Cardiovasc Diabetol; 2008 Oct; 7():30. PubMed ID: 18922158 [TBL] [Abstract][Full Text] [Related]
11. Relative androgen deficiency in relation to obesity and metabolic status in older men. Chen RY; Wittert GA; Andrews GR Diabetes Obes Metab; 2006 Jul; 8(4):429-35. PubMed ID: 16776750 [TBL] [Abstract][Full Text] [Related]
12. Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease? Saad F Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():52-9. PubMed ID: 23280867 [TBL] [Abstract][Full Text] [Related]
13. The prevalence and predictors of androgen deficiency in Taiwanese men with type 2 diabetes. Liu RT; Chung MS; Wang PW; Chen CD; Lee JJ; Lee WC; Chancellor MB; Yang KD; Chuang YC Urology; 2013 Jul; 82(1):124-9. PubMed ID: 23676359 [TBL] [Abstract][Full Text] [Related]
14. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study. Luque Otero M; Martell Claros N; Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479 [TBL] [Abstract][Full Text] [Related]
15. Androgens, insulin resistance and vascular disease in men. Kapoor D; Malkin CJ; Channer KS; Jones TH Clin Endocrinol (Oxf); 2005 Sep; 63(3):239-50. PubMed ID: 16117808 [TBL] [Abstract][Full Text] [Related]
16. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542 [TBL] [Abstract][Full Text] [Related]
17. Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus. Ogbera AO West Afr J Med; 2011; 30(4):277-81. PubMed ID: 22669833 [TBL] [Abstract][Full Text] [Related]
18. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes]. Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962 [TBL] [Abstract][Full Text] [Related]
19. The prevalence of Hypogonadism among diabetic and non-diabetic men in Jordan. Al Hayek AA; Khawaja NM; Khader YS; Jaffal SK; Ajlouni KM J Diabetes Complications; 2014; 28(2):135-40. PubMed ID: 24388552 [TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes mellitus and testosterone: a meta-analysis study. Corona G; Monami M; Rastrelli G; Aversa A; Sforza A; Lenzi A; Forti G; Mannucci E; Maggi M Int J Androl; 2011 Dec; 34(6 Pt 1):528-40. PubMed ID: 20969599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]